The Question of Maintenance Therapy: For Whom and How Long? image

The Question of Maintenance Therapy: For Whom and How Long?

Sep 21, 2021
06:00PM - 07:00PM EDT
Online Event
Overview

With differing opinions in the specialist field about multiple myeloma maintenance therapy, it's hard to make educated decisions as a patient about whether or not it's right for you. Questions to consider include:

  • Is maintenance therapy right for me?
  • How long do I expect to be on maintenance therapy?
  • What will the side effects be like?
  • Should I get a second opinion? 

Multiple Myeloma Specialist Dr. Ghulam (Manni) Mohyuddin joins us to discuss this important topic. 

Agenda
06:00 PM
Introductions
Audrey Burton-Bethke
Audrey introduces the meeting agenda and featured speaker. 
06:05 PM
Presentation
Ghulam (Manni) Mohyuddin, MD
Dr. Manni presents on the complicated topic of maintenance therapy, guiding us to answer the questions: who is it for? and for how long? 
06:40 PM
Questions and Answers
Audience
The session is opened up for questions from the audience. 
Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Ghulam (Manni) Mohyuddin, MD

Ghulam (Manni) Mohyuddin, MD

Dr. Mohyuddin completed his medical training at the prestigious Aga Khan University in Pakistan. He completed his internal medicine residency at the University of Kansas where he developed a passion for medical education and treating hematological malignancies. After residency, he pursued Chief Residency at the University of Kansas, focusing on mechanisms of novel educational delivery and improving access to research for trainees. He completed his fellowship at the University of Kansas, developing a clinical and research interest in multiple myeloma, drug repurposing, quality of scientific methods, end of life, cost-effective/evidence-based care and medical education. He enjoys the outdoors tremendously, and that drew him to life in Utah where he is currently an Assistant Professor at the Huntsman Cancer Institute with a focus on multiple myeloma.